Review



lead ecg recordings  (ADInstruments)


Bioz Verified Symbol ADInstruments is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ADInstruments lead ecg recordings
    Lead Ecg Recordings, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 215 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lead ecg recordings/product/ADInstruments
    Average 96 stars, based on 215 article reviews
    lead ecg recordings - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    96
    ADInstruments lead ecg recordings
    Lead Ecg Recordings, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lead ecg recordings/product/ADInstruments
    Average 96 stars, based on 1 article reviews
    lead ecg recordings - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Mouse Specifics noninvasive ecg recording platform
    Noninvasive Ecg Recording Platform, supplied by Mouse Specifics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/noninvasive ecg recording platform/product/Mouse Specifics
    Average 86 stars, based on 1 article reviews
    noninvasive ecg recording platform - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Technology Development Co single channel mi rhythm holter ecg recorder
    Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of <t>EEG/ECG</t> data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .
    Single Channel Mi Rhythm Holter Ecg Recorder, supplied by Technology Development Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single channel mi rhythm holter ecg recorder/product/Technology Development Co
    Average 86 stars, based on 1 article reviews
    single channel mi rhythm holter ecg recorder - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Data Sciences International ecg recordings
    Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
    Ecg Recordings, supplied by Data Sciences International, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg recordings/product/Data Sciences International
    Average 86 stars, based on 1 article reviews
    ecg recordings - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Micromed Inc 12 lead electrocardiography recorder
    Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
    12 Lead Electrocardiography Recorder, supplied by Micromed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/12 lead electrocardiography recorder/product/Micromed Inc
    Average 86 stars, based on 1 article reviews
    12 lead electrocardiography recorder - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Fukuda Denshi Co digital ecg recorder
    Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with <t>echocardiography.</t> The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; <t>ECG,</t> n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
    Digital Ecg Recorder, supplied by Fukuda Denshi Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/digital ecg recorder/product/Fukuda Denshi Co
    Average 86 stars, based on 1 article reviews
    digital ecg recorder - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Fukuda Denshi Co ecg recorder cardimax fx 2111
    <t>ECG</t> changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.
    Ecg Recorder Cardimax Fx 2111, supplied by Fukuda Denshi Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg recorder cardimax fx 2111/product/Fukuda Denshi Co
    Average 86 stars, based on 1 article reviews
    ecg recorder cardimax fx 2111 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Abbott Laboratories multiple electrocardiogram recording patches
    <t>ECG</t> changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.
    Multiple Electrocardiogram Recording Patches, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/multiple electrocardiogram recording patches/product/Abbott Laboratories
    Average 86 stars, based on 1 article reviews
    multiple electrocardiogram recording patches - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    Image Search Results


    Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of EEG/ECG data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .

    Journal: Frontiers in Human Neuroscience

    Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

    doi: 10.3389/fnhum.2026.1743936

    Figure Lengend Snippet: Schematic overview of the proposed pilot fatigue detection framework. The pipeline consists of three sequential stages: (1) Signal preprocessing and segmentation of EEG/ECG data, (2) Pivotal feature selection using ANOVA and EEG channel selection using SVM-based AUC ranking, and (3) Final fatigue classification using the XGBoost model. With permission from .

    Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

    Techniques: Selection

    Illustration of the ECG device. The single-channel Mi-Rhythm Holter recorder includes (a) the host unit, (b) a protective silicone sleeve, and (c) disposable electrode patches. This compact design allows for unobtrusive recording of cardiac activity.

    Journal: Frontiers in Human Neuroscience

    Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

    doi: 10.3389/fnhum.2026.1743936

    Figure Lengend Snippet: Illustration of the ECG device. The single-channel Mi-Rhythm Holter recorder includes (a) the host unit, (b) a protective silicone sleeve, and (c) disposable electrode patches. This compact design allows for unobtrusive recording of cardiac activity.

    Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

    Techniques: Activity Assay

    Visualization of the EEG and ECG signal preprocessing and segmentation. Both EEG and ECG signals are filtered (0.5–30 Hz) and segmented into 2-s epochs with a 50% overlap using a sliding window technique. This synchronized segmentation ensures that each data sample contains aligned multimodal information.

    Journal: Frontiers in Human Neuroscience

    Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

    doi: 10.3389/fnhum.2026.1743936

    Figure Lengend Snippet: Visualization of the EEG and ECG signal preprocessing and segmentation. Both EEG and ECG signals are filtered (0.5–30 Hz) and segmented into 2-s epochs with a 50% overlap using a sliding window technique. This synchronized segmentation ensures that each data sample contains aligned multimodal information.

    Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

    Techniques:

    Comparison of single-channel SVM classification performance (AUC) utilizing features from single vs. fused frequency bands. The bar chart compares the AUC of single-channel SVM classifiers using features from individual frequency bands versus fused features from all 4 bands (red bars). Data are obtained based on 10-fold cross-clip cross-validation. Adapted with permission from .

    Journal: Frontiers in Human Neuroscience

    Article Title: To assure aviation safety: the pilot fatigue detection based on short-term multimodal physiological signals

    doi: 10.3389/fnhum.2026.1743936

    Figure Lengend Snippet: Comparison of single-channel SVM classification performance (AUC) utilizing features from single vs. fused frequency bands. The bar chart compares the AUC of single-channel SVM classifiers using features from individual frequency bands versus fused features from all 4 bands (red bars). Data are obtained based on 10-fold cross-clip cross-validation. Adapted with permission from .

    Article Snippet: Pilot ECG signals were collected using a single-channel Mi-Rhythm Holter ECG recorder (Shenzhen Ruikang Hongye Technology Development Co., Ltd., China) at a sampling rate of 250 Hz.

    Techniques: Comparison, Biomarker Discovery

    Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

    Journal: Antioxidants

    Article Title: Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity

    doi: 10.3390/antiox15010027

    Figure Lengend Snippet: Ferroptosis inhibitors fail to rescue cardiac dysfunction. ( A ) Brief schedule of in vivo experiment. C57BL/6J mice were treated with ferrostatin-1 (Fer-1) or liproxstatin-1 (Lip-1) 24 h before doxorubicin injection and were dosed every 24 h. A single dose of doxorubicin was administered intraperitoneally once on day 1. Experimental groups: Vehicle, DOX (20 mg/kg, i.p.), DOX + Fer-1 (2 mg/kg, i.p.), and DOX + Lip-1 (10 mg/kg, i.p.) ( B ) The survival graph of mice from different groups was shown by Kaplan–Meier survival analysis. ( C ) Three days after intraperitoneal injection of doxorubicin, the mouse cardiac function was analyzed with echocardiography. The echocardiography data showed decreased fractional shortening and ejection fraction in mice treated with doxorubicin and Fer-1 or Lip-1. Survival rate, n = 5 per group; ECG, n = 5 per group. ( D ) Bar graph representation of the heart weight to body weight ratio of mice. ( E ) 3,3’-Diaminobenzidine immunohistochemical staining for 4-hydroxynonenal (4-HNE) in the mouse heart tissue; scale bars, 200 µm (left panel). Quantification of 4-HNE-specific 3,3’-Diaminobenzidine staining (right panel). ( F ) Bar graph representation of the N-terminal pro B-type natriuretic peptide (NT-proBNP) of mice. ( G ) Masson’s trichrome and Sirius red staining of fibrosis in the mouse heart (left panel) and quantification (right panel). ( H ) Western blot of ferroptosis cell death markers in mouse heart tissues treated with doxorubicin and Fer-1 or Lip-1. heart weight to body weight, n = 3 per group; 4-HNE, n = 3 per group; NT-proBNP, n = 7 per group; Masson’s trichrome and Sirius red, n = 3 per group; Western blots, n = 3 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test for panels ( C , F ), and the Kruskal–Wallis test was used for panels ( D , E , G ), ns, no significance, * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.

    Article Snippet: ECG recordings were conducted for 22 days, with each mouse housed individually in a cage equipped with a receiver (RPC-1, Data Sciences International).

    Techniques: In Vivo, Injection, Immunohistochemical staining, Staining, Western Blot, Comparison

    Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.

    Journal: Antioxidants

    Article Title: Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity

    doi: 10.3390/antiox15010027

    Figure Lengend Snippet: Ferroptosis inhibitors do not alleviate doxorubicin-induced arrhythmic changes in mice. ( A ) Electrocardiogram (ECG) traces recorded on day 1 after DOX administration with or without ferroptosis inhibitors, showing various arrhythmic events, including tachyarrhythmia, frequent premature ventricular contractions, irregular rhythm, and cardiac arrest. Red arrows indicate representative arrhythmic events, including premature ventricular contractions and irregular R−R intervals. ( B ) ECG traces recorded on day 21, demonstrating the progression of arrhythmic changes, including atrioventricular (AV) block and bradycardia with AV block, indicated by red arrows. n = 4 per group. Data are presented as mean ± S.D., where n represents the number of individual mice per group. Statistical significance was determined by one-way ANOVA followed by Sidak’s multiple comparison test.

    Article Snippet: ECG recordings were conducted for 22 days, with each mouse housed individually in a cage equipped with a receiver (RPC-1, Data Sciences International).

    Techniques: Blocking Assay, Comparison

    ECG changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.

    Journal: Frontiers in Physiology

    Article Title: A comparative study on L-thyroxine treatment and sesame oil supplementation in experimentally induced hypothyroidism in rats

    doi: 10.3389/fphys.2025.1606528

    Figure Lengend Snippet: ECG changes and cardiac enzymes changes in the different studied groups: a: significance from the control group by LSD at p ≤ 0.05. b: Significance from the hypothyroid group by LSD at p ≤ 0.05. c: Significance from the L-thyroxine-treated hypothyroid group by LSD at p ≤ 0.05. d: Significance from the sesame oil-treated hypothyroid group by LSD at p ≤ 0.05.

    Article Snippet: When the stage of surgical anesthesia was reached, an ECG recording was performed using the ECG recorder Cardimax FX-2111 (Fukuda Denshi Co., Ltd., Japan).

    Techniques: Control